InvestorsHub Logo
Post# of 252526
Next 10
Followers 831
Posts 119993
Boards Moderated 17
Alias Born 09/05/2002

Re: DewDiligence post# 174049

Monday, 02/17/2014 12:46:16 PM

Monday, February 17, 2014 12:46:16 PM

Post# of 252526
NVS acquires CoStim Pharmaceuticals (private) for undisclosed price:

http://www.novartis.com/newsroom/media-releases/en/2014/1762334.shtml

Novartis announced today that it is broadening its cancer immunotherapy research program with the acquisition of CoStim Pharmaceuticals Inc., a Cambridge, MA-based, privately held biotechnology company focused on harnessing the immune system to eliminate immune-blocking signals from cancer.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.